According to Array Technologies's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.17701. At the end of 2023 the company had a P/S ratio of 1.61.
Year | P/S ratio | Change |
---|---|---|
2023 | 1.61 | -9.29% |
2022 | 1.78 | -29.07% |
2021 | 2.50 | -60.11% |
2020 | 6.28 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Novartis NVS | 3.94 | 235.00% | ๐จ๐ญ Switzerland |
Eli Lilly LLY | 20.4 | 1,633.26% | ๐บ๐ธ USA |
Amgen AMGN | 5.19 | 341.34% | ๐บ๐ธ USA |
AstraZeneca AZN | 4.82 | 309.41% | ๐ฌ๐ง UK |
Onconova Therapeutics ONTX | 92.5 | 7,758.78% | ๐บ๐ธ USA |